Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

NTHI Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Neonc Technologies Holdings, Inc.NASDAQ: NTHI

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures turns positive

Q1 FY2026 capital expenditures was $3, compared with -$5 a year earlier. Trailing-twelve-month capital expenditures was $8.

Context

  • Capital expenditures amounted to 1250.3% of revenue in FY2025.

What to watch

Whether quarterly capital expenditures holds near $3 or moves back toward the trailing-twelve-month quarterly average of $2.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3— QoQ
Last fiscal yearDec 2025
-$500K— YoY
LTMMar 2026
$8— YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+160.0%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(500K) USD
Year-over-year change
—

Capital Expenditures vs competitors

How NTHI compares with its peers on the latest reported figures

No competitor Capital Expenditures figures are available to compare.

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Intrinsic Alpha fair value

Locked

Current Price

$4.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.